IBM, Cleveland Clinic team to accelerate discovery in healthcare

IBM, Cleveland Clinic team to accelerate discovery in healthcare

Market news |
Academic medical center Cleveland Clinic and tech giant IBM have announced a planned 10-year partnership to establish a joint Cleveland Clinic - IBM center with the mission of fundamentally advancing the pace of discovery in healthcare and life sciences through the use of high-performance computing on the hybrid cloud, artificial intelligence (AI), and quantum computing technologies.
By Rich Pell


The Discovery Accelerator collaboration is anticipated to build a robust research and clinical infrastructure to empower big data medical research in ethical, privacy preserving ways, discoveries for patient care, and novel approaches to public health threats such as the COVID-19 pandemic. Through the Discovery Accelerator, the researchers plan to use advanced computational technology to generate and analyze data to help enhance research in the Cleveland Clinic’s new Global Center for Pathogen Research & Human Health, in areas such as: genomics, single cell transcriptomics, population health, clinical applications, and chemical and drug discovery.

As part of the collaboration, IBM plans to install its first private sector, on-premises IBM Quantum System One in the United States, to be located on Cleveland Clinic’s campus in Cleveland. The company also plans to install the first of its next-generation 1,000+ qubit quantum systems at a client facility, also to be located in Cleveland, in the coming years.

This quantum program, say the organizations, will be designed to actively engage with universities, government, industry, startups and other relevant organizations. It will leverage Cleveland Clinic’s global enterprise to serve as the foundation of a new quantum ecosystem for life sciences, focused on advancing quantum skills and the mission of the center.

“Through this innovative collaboration, we have a unique opportunity to bring the future to life,” says Tom Mihaljevic, M.D., CEO and President of Cleveland Clinic. “These new computing technologies can help revolutionize discovery in the life sciences. The Discovery Accelerator will enable our renowned teams to build a forward-looking digital infrastructure and help transform medicine, while training the workforce of the future and potentially growing our economy.”

Arvind Krishna, Chairman and Chief Executive Officer of IBM says, “The COVID-19 pandemic has spawned one of the greatest races in the history of scientific discovery – one that demands unprecedented agility and speed. At the same time, science is experiencing a change of its own – with high-performance computing, hybrid cloud, data, AI, and quantum computing, being used in new ways to break through long-standing bottlenecks in scientific discovery. Our new collaboration with Cleveland Clinic will combine their world-renowned expertise in healthcare and life sciences with IBM’s next-generation technologies to make scientific discovery faster, and the scope of that discovery larger than ever.”

Leveraging the combined innovations of AI, quantum computing, and hybrid cloud technologies, say the organizations, will supercharge new generations of information technology and fuel important advances in science. IBM will provide access to a variety of research and commercial technologies, education and tools to assist Cleveland Clinic in accelerating discovery in healthcare and life science, including:

  • RoboRXN, a cloud-based platform that combines AI models and robots to help scientists design and synthesize new molecules remotely
  • The IBM Functional Genomics Platform, a cloud-based repository and research tool, which uses novel approaches to reveal the molecular features in viral and bacterial genomes to help accelerate discovery of molecular targets required for drug design, test development and treatment
  • Deep Search, which helps researchers access structured and unstructured data quickly
  • High-Performance Hybrid Cloud Computing technologies that can enable researchers to “burst” their workloads into the cloud and access the resources they need at scale

Quantum computing, say the organizations, has the potential to have an immense impact on key healthcare challenges, such as the discovery of new molecules that can serve as the basis of new pharmaceutical breakthroughs and spur the development of new medicines and could help enhance the ability to derive deep insight from complex data that is at the heart of some of the largest challenges in healthcare. The Discovery Accelerator will leverage IBM’s multi-year roadmap for advancing quantum computing, bringing its revolutionary capabilities into the hands of scientists and practitioners in healthcare and life sciences.

In addition to an on-premises quantum system, Cleveland Clinic will also have access to IBM’s fleet of currently more than 20 quantum systems, accessible via the cloud. IBM is targeting to unveil its first next generation 1,000+ qubit quantum system in 2023, and Cleveland Clinic is planned to be the site of the first private-sector on-premises system.

Cleveland Clinic

Related articles:
Quantum ML may speed discovery of COVID-19 treatments
AI speeds up precision medicine, says IBM Watson study
IBM unveils roadmap to open quantum software ecosystem
Free quantum computing cloud access for COVID-19 response
Quantum-inspired technology targets COVID-19 challenges

Linked Articles